Breakthroughs Delivered

Advancing Vaccines and BioTherapeutics

Our GMP, Your IND

Advancing Vaccines and BioTherapeutics

Solutions Through Immunology

Advancing Vaccines and BioTherapeutics

About ABL

Revolutionary treatments can cause changes in previously unobserved endpoints. ABL’s immunologists have decades of experience working with cutting-edge vaccines and therapeutics. We specialize in solving the hard problems for all product types.

Learn More

ABL, Inc. Acquires GMP Virus Manufacturing Facility in France

With this acquisition, ABL establishes itself as a premier global CMO for the production of virus-based therapies and vaccines with the ability to significantly increase client responsiveness and schedule flexibility. The site in Strasbourg, France will be operated by ABL’s wholly owned subsidiary, ABL Europe S.A.S. to produce live virus-based gene therapies, oncolytic therapies, and vaccines on a contract basis for clinical and commercial supply.

Read More